
About Alpa Expoim Private Limited
Data last updated:
Alpa Expoim Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 September 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2005PTC140719. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjay Loomba and Sarah Loomba.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 101 Sitaram Mansion 718/21 Joshi Road Karol Bagh, New Delhi, Delhi, India – 110005.
As per the financials filed for FY 2021, the company reported a revenue of ₹42,390. For the same year it recorded a net profit of ₹40,290 (net margin 95%) and EBITDA of ₹40,290 (EBITDA margin 95%).
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website jodasexpoim.com.
Company details
CIN history
Alpa Expoim has one previous CIN (Corporate Identification Number): U00063DL2005PTC140719. The current CIN is U51909DL2005PTC140719, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909DL2005PTC140719 | Current |
| U00063DL2005PTC140719 | Previous |
Contact details
Alpa Expoim Private Limited's registered office is in New Delhi, Delhi. Its website is jodasexpoim.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address101 Sitaram Mansion 718/21 Joshi Road Karol Bagh, New Delhi, Delhi, India – 110005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alpa Expoim Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alpa Expoim is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alpa Expoim Private Limited, buy the company report.
Financials of Alpa Expoim Private Limited
FY 2021 filings availableAlpa Expoim Private Limited reported revenue of ₹42,390 for FY 2021.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹40,290 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹40,290 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 95% | ||||
| Net Profit Margin | 95% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alpa Expoim Private Limited, buy the company report.
Board of directors of Alpa Expoim Private Limited
Alpa Expoim has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Loomba | Director | 14 Sep 2005 | 21 Years 2 Months | Current |
| Sarah Loomba | Director | 23 Jan 2009 | 17 Years 9 Months | Current |
Auditor
Alpa Expoim Private Limited is audited by P.C. BINDAL & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.C. BINDAL & CO. | FY 2017 | 003824N |
Shareholding
The shareholding of Alpa Expoim Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Alpa Expoim Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alpa Expoim Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alpa Expoim Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alpa Expoim has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Alpa Expoim Private Limited, buy the company report.
Recent activity
Alpa Expoim Private Limited has 5 board changes on record since 2005: 2 appointments and 3 cessations. The latest: Jyoti Loomba ceased to be Director on 04 Oct 2017.
Frequently asked questions
Alpa Expoim is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 September 2005 (21+ years old) and is registered under CIN U51909DL2005PTC140719.
Alpa Expoim has 2 current directors:
- Sanjay Loomba - Director
- Sarah Loomba - Director
The latest financial statements of Alpa Expoim on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
No. Alpa Expoim has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Alpa Expoim is U51909DL2005PTC140719. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alpa Expoim was incorporated on 14 September 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Jyoti Loomba ceased to be Director on 04 Oct 2017. Sarah Loomba was appointed as Director on 23 Jan 2009. Sarah Loomba ceased to be Alternate Director on 14 Dec 2008. Alpa Expoim has 5 board changes on record in total.
Alpa Expoim can be reached through the website jodasexpoim.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Alpa Expoim is at 101 Sitaram Mansion 71821 Joshi Road Karol Bagh, New Delhi, Delhi, India – 110005.
Alpa Expoim operates in the pharma industry, in the drug formulation and development segment.

